Cytokinetics IncEquity-NMS: CYTK
Equity-NMS: CYTK
$73.98
+1.74
(3 Mar)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$73.98
Open
$73.98
Today’s high
$75.03
Today’s low
$72.53
52W low
$25.98
52W high
$110.25
1Y
76.35%
5Y
59.09%
PE
-14.13
EPS (TTM)
-5.52
Shares O/S
103.00M
Market cap
7.62B
Insights
CYTK is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Cytokinetics Inc

Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. The Company's clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure with reduced ejection fraction (HFrEF); CK-136, a cardiac troponin activator for the treatment of heart failure and other diseases; reldesemtiv , a fast skeletal muscle troponin activator (FSTA) for the treatment of people living with debilitating diseases and conditions associated with muscular weakness; aficamten, a cardiac myosin inhibitor designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy (HCM); and CK-136 an novel small molecule cardiac troponin activator.

.


FAQs

Can I buy Cytokinetics Inc shares in India?
How to buy Cytokinetics Inc shares in India?
What is the share price of Cytokinetics Inc?
What is the Market Capitalization of Cytokinetics Inc?
What is the PE ratio of Cytokinetics Inc?
Is Cytokinetics Inc a good stock to buy?
In which sector / industry does Cytokinetics Inc operate?